Senior Director, Oncology Small Molecule

Discovery Oncology is seeking a visionary and strategic leader to shape and drive the discovery and advancement of the next generation of our Company's Oncology small molecule therapeutics. Come join an incredible team steeped in a history of scientific excellence and successful drug discovery. The successful candidate will lead a team at our company's Boston site delivering on the small molecule Oncology pipeline.

They will be the strategic leader for Oncology small molecule therapeutics in Boston, with opportunities to contribute across additional modalities. They will develop and execute a comprehensive pipeline strategy, partnering across our company to expand our portfolio. This leader will work tightly with chemistry, clinical, translational, and business development to build and progress an effective pipeline of compelling medicines, from discovery through late-stage development.

The successful candidate will have a strong record of scientific excellence, thoughtful strategic planning, late-stage research and IND experience, and inspiring people leadership.

• Develop and execute a forward-thinking pipeline strategy, shaping the future of our Company's Oncology therapeutics with a focus on small molecules.
• Be a strategic thought leader for the employment of small molecules to create effective, tolerable, and combinable medicines that are both first-in-class and best-in-class.
• Leverage your deep understanding of cancer biology (including intrinsic pathways and key cancer drivers) and the current internal and external oncology landscape to evaluate the opportunity of new therapeutics and drive portfolio decisions.
• Provide strategic oversight for programs as they transition from early discovery into and through late-stage clinical development, ensuring continuity and alignment with the overall asset strategy.
• Drive key milestones for pipeline advancement, from preclinical candidate selection through to IND-enabling studies and support for early clinical development.
• Ensure compelling engagement with regulatory agencies.
• Lead business development evaluations from a scientific perspective, identifying and championing external assets and platforms that align with our strategic vision.
• As a member of the Discovery Oncology Leadership team, meaningfully contribute to the development and execution of strategy and the growth and development of staff.
• Act as an experienced Program Lead and mentor others to become strong Program Leaders.
• Foster a high-performance culture of collaboration, engagement, self-accountability, and inclusion.
• Establish strong relationships within highly collaborative, multidisciplinary teams to effectively drive drug discovery initiatives.

• Ph.D. in Biology, Oncology, Pharmacology, Biochemistry, Toxicology, Biophysics, Immunology, or a related STEM subject area with 10+ years of post-degree experience in industry or equivalent.
• An extensive background in cancer biology with a proven ability to translate deep scientific insights into drug development strategies from discovery through late-stage development.
• Evidence of innovative approaches to small molecule design, particularly induced proximity.
• A proven track record of successfully advancing multiple well-designed investigative small molecule drug candidates into the clinic, with a focus on patient experience and successful clinical execution.
• Clear experience in late program leadership partnering with regulatory, translational sciences, and clinical development.
• Direct, hands-on experience writing IND modules and filings.
• Experience managing a group of senior and junior scientists with a track record of achievements, including project leadership and strategic contributions.
• Ability to build strong relationships within highly collaborative, multidisciplinary teams to effectively drive drug discovery initiatives.
• Excellent attention to detail and strong communication (oral and written) skills.
• Highly self-motivated and capable of prioritizing deliverables.

• Preference will be given to candidates with a large breadth of small molecule experience, including novel approaches.
• Experience with modalities beyond traditional small molecules is beneficial, particularly including small molecule payloads.

#EligibleforERP

Required Skills:

Cancer Research, Drug Development, External Collaboration, High Performance Team Building, Immunotherapy, IND Submission, Innovation, Investigational New Drug (IND), Motivation Management, Multidisciplinary Collaboration, Oncology, People Leadership, Program Leadership, Project Leadership, Small Molecules, Strategic Management, Strategic Planning

US and Puerto Rico Residents Only:
Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities.

As an Equal Employment Opportunity Employer, we provide equal opportunities to all employees and applicants for employment and prohibit discrimination…